TAMPERE, Finland, July 03, 2025 (GLOBE NEWSWIRE) -- The energy storage facility delivered by Merus Power to Lappeenranta, Finland, has been completed and put into market use on 15 May 2025. The energy storage facility is owned by a joint venture between Ardian’s Clean Energy Evergreen Fund and the local energy provider Lappeenrannan Energia. It is one of the largest energy storage facilities in use on the Finnish electricity market with an output of approximately 38 megawatts and energy of 43 megawatt hours. The completion of the project is significant for Merus Power, as it is the largest energy storage facility manufactured by the company.
LUXEMBOURG, July 3, 2025 /PRNewswire/ -- Global alternative lender Bizcap has announced its launch into Luxembourg, establishing its first operational footprint in continental Europe.
Following its...
Agustín Carstens, Former General Manager of the Bank for International Settlements, and Sanjiv Bajaj Chairman of Bajaj Finserv, Also Join the Board
SINGAPORE, July 3,...
MUNICH, July 3, 2025 /PRNewswire/ -- According to Yole's Thermal Imaging and Sensing 2024 Market and Technology Report, Teledyne Flir, Raytron, Hikmicro, Lynred, and Seek...
Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...
New York City, NY, July 03, 2025 (GLOBE NEWSWIRE) -- In 2025, Nixol, a plant-based dietary supplement, made its debut in the United Kingdom and Ireland, marking a significant entry into the wellness supplement market. Designed to support healthy weight management, boost metabolism, and curb cravings, Nixol has positioned itself as a natural, vegan-friendly alternative to traditional weight loss solutions. Unlike products that rely on synthetic stimulants or restrictive diets, Nixol leverages a blend of carefully selected, science-backed ingredients to promote sustainable fat reduction and overall well-being. This article provides an in-depth exploration of Nixol’s launch, its formulation, claims, scientific backing, customer feedback, and the broader context of its market entry, while critically examining its potential effectiveness and limitations. Visit Official Website
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...